Literature DB >> 11426657

Novel macrolactins as antibiotic lactones from a marine bacterium.

T Nagao1, K Adachi, M Sakai, M Nishijima, H Sano.   

Abstract

Seven new macrolactins (named G~M) and known macrolactins A and F were isolated from a culture broth of Bacillus sp. PP19-H3. The strain had been isolated from the macroalga, Schizymenia dubyi. Macrolactin A, which was 24-membered lactone, had previously been reported to show antibacterial, cytotoxic and antiviral activities. The new macrolactins include 22-membered ring or dicyclic lactone in addition to geometric isomers of known macrolactins A and F. The antibacterial activities of all the macrolactins examined in this study were relatively weak.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11426657     DOI: 10.7164/antibiotics.54.333

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  12 in total

1.  Antimicrobial Activity of Bacillus amyloliquefaciens ANT1 Toward Pathogenic Bacteria and Mold: Effects on Biofilm Formation.

Authors:  Rosa Anna Nastro; Anthony Arguelles-Arias; Marc Ongena; Amelia Di Costanzo; Marco Trifuoggi; Marco Guida; Patrick Fickers
Journal:  Probiotics Antimicrob Proteins       Date:  2013-12       Impact factor: 4.609

Review 2.  Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistance.

Authors:  Noer Kasanah; Mark T Hamann
Journal:  Curr Opin Investig Drugs       Date:  2004-08

3.  Recent Applications of Acyclic (Diene)iron Complexes and (Dienyl)iron Cations in Organic Synthesis.

Authors:  William A Donaldson; Subhabrata Chaudhury
Journal:  European J Org Chem       Date:  2009-08

4.  Metabolic drug-drug interaction potential of macrolactin A and 7-O-succinyl macrolactin A assessed by evaluating cytochrome P450 inhibition and induction and UDP-glucuronosyltransferase inhibition in vitro.

Authors:  Soo Hyeon Bae; Min Jo Kwon; Jung Bae Park; Doyun Kim; Dong-Hee Kim; Jae-Seon Kang; Chun-Gyu Kim; Euichaul Oh; Soo Kyung Bae
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

5.  7-O-malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepacia.

Authors:  Magally Romero-Tabarez; Rolf Jansen; Marita Sylla; Heinrich Lünsdorf; Susanne Häussler; Dwi A Santosa; Kenneth N Timmis; Gabriella Molinari
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

6.  Anti-Allergic Compounds from the Deep-Sea-Derived Actinomycete Nesterenkonia flava MCCC 1K00610.

Authors:  Chun-Lan Xie; Qingmei Liu; Jin-Mei Xia; Yuanyuan Gao; Quan Yang; Zong-Ze Shao; Guangming Liu; Xian-Wen Yang
Journal:  Mar Drugs       Date:  2017-03-14       Impact factor: 5.118

7.  Response surface methodology optimization of fermentation conditions for rapid and efficient accumulation of macrolactin A by marine Bacillus amyloliquefaciens ESB-2.

Authors:  Shan He; Hongqiang Wang; Bin Wu; Hui Zhou; Peng Zhu; Rui Yang; Xiaojun Yan
Journal:  Molecules       Date:  2012-12-28       Impact factor: 4.411

Review 8.  Deep Hypersaline Anoxic Basins as Untapped Reservoir of Polyextremophilic Prokaryotes of Biotechnological Interest.

Authors:  Stefano Varrella; Michael Tangherlini; Cinzia Corinaldesi
Journal:  Mar Drugs       Date:  2020-01-30       Impact factor: 5.118

Review 9.  Diversity of secondary metabolites from marine Bacillus species: chemistry and biological activity.

Authors:  Muhammad Abdul Mojid Mondol; Hee Jae Shin; Mohammad Tofazzal Islam
Journal:  Mar Drugs       Date:  2013-08-12       Impact factor: 5.118

10.  Antibacterial and antiyeast compounds from marine-derived bacteria.

Authors:  Muhammad Abdul Mojid Mondol; Hee Jae Shin
Journal:  Mar Drugs       Date:  2014-05-13       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.